Monday, March 17, 2025 | 03:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USFDA drug approvals at all-time high; Indian firms get 35-40% of nods

The regulator has bettered last year's numbers with 971 approval actions this year

drugs
Premium

Sohini Das Mumbai
The US Food and Drug Administration (USFDA) has granted the highest number of drug approvals in its history this year. The regulator has bettered last year’s numbers with 971 approval actions this year. This includes 781 final nods and 190 tentative go-aheads. 

Indian firms account for 35-40 per cent of the global nods. Analysts feel that rising rate of approvals would on one hand increase competition in the US generic market, and on the other allow new players to enter. 

However, analysts expect the growth in approvals to flatten as the number of filings has seen a dip

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in